Evidence map›Paper›PMID 9108120›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Target-independent cholinergic differentiation in the rat sympathetic nervous system.

M K Schäfer, B Schütz, E Weihe, L E Eiden

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Myocardial Infarction Causes Transient Cholinergic Transdifferentiation of Cardiac Sympathetic Nerves via gp130.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Tlx3 controls cholinergic transmitter and Peptide phenotypes in a subset of prenatal sympathetic neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  12. Review
  13. Article
  14. The sympathetic neurotransmitter switch depends on the nuclear matrix protein Satb2.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Neurotrophin-3 promotes the cholinergic differentiation of sympathetic neurons.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M K SchäferDepartment of Anatomy and Cell Biology, Philipps University, Marburg, Germany.
B Schütz
E Weihe
L E Eiden
National Institutes of Health · USNational Institute of Mental Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical coding in the sympathetic nervous system involves both noradrenergic and, for a minority of neurons, cholinergic neurotransmission. The expression of the cholinergic phenotype in the developing sympathetic nervous system was examined to determine if coding for cholinergic transmission occurs before or after innervation of peripheral target organs. The vesicular acetylcholine transporter (VAChT) and choline acetyltransferase, the products of the "cholinergic gene locus" determining the cholinergic phenotype, were expressed in principal cells of the paravertebral, but only rarely in prevertebral, sympathetic chains as early as embryonic day 14. A subpopulation of VAChT- and choline acetyltransferase-positive sympathetic ganglion cells persisted throughout development of the stellate and more caudal paravertebral ganglia into anatomically distinct cell groups, and into adulthood. The forepaw eccrine sweat glands, innervated exclusively by the stellate ganglion, received VAChT-positive nerve terminals at least as early as postembryonic day 4, coincident with the development of the sweat glands themselves. These terminals, like the VAChT-positive cell bodies of the developing stellate ganglion, have some noradrenergic traits including expression of tyrosine hydroxylase, but did not express the vesicular monoamine transporter, and are therefore not functionally noradrenergic. Development of the cholinergic phenotype in principal cells of the sympathetic paravertebral ganglia apparently occurs via receipt of instructive cues, or selection, within the sympathetic chain itself or perhaps even during migration of the cells of the neural crest from which the paravertebral ganglia arise.

Indexed as

Membrane Transport ProteinsNeuropeptidesVesicular Transport ProteinsAnimalsBiomarkersCarrier ProteinsCell DifferentiationCholinergic FibersEmbryonic and Fetal DevelopmentFemaleImmunohistochemistryMembrane GlycoproteinsPregnancyRatsSympathetic Nervous SystemVesicular Acetylcholine Transport ProteinsBiomarkersCarrier ProteinsMembrane GlycoproteinsMembrane Transport ProteinsNeuropeptidesSlc18a3 protein, ratVesicular Acetylcholine Transport ProteinsVesicular Biogenic Amine Transport ProteinsVesicular Monoamine Transport ProteinsVesicular Transport Proteins

Identifiers

PMID9108120
PMCPMC20583
OpenAlexW2005734269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.